Companies/Pazoo, Inc.

Company profile

Pazoo, Inc.

OTC: PZOO · Healthcare · Medical - Diagnostics & Research

PublicHQ East Hanover, NJReports USD

#1143 of 1,394 Healthcare companies by revenuebottom-decile growth

EA Score

——

FH —DQ —GM —SS 29

v0.1 · 5/100 weight · pillars only

↑ Piotroski F, listing tenure · ↓ revenue growth (YoY), 3-yr revenue growth

Methodology →

Revenue TTM

Rev growth YoY (TTM)

-100.0%

Net income (FY)

-$4.8M

Employees

Market cap

$26.9k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02017

Net income-$4.8M-$4.8M2017

Operating income-$2.2M-$2.2M2017

Total assets$129.5k$129.5k2017

Liabilities$11.2M$11.2M2017

Equity-$11.1M-$11.1M2017

Revenue trend

FY2011 – FY2017 · USD

$2.2k

FY11

$119.3k

FY12

$52.8k

FY13

$111.3k

FY14

$26.7k

FY15

$30.5k

FY16

FY17

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Pazoo, Inc. booked $0 in FY2017 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Real Brands, Inc.——Net Medical Xpress Solutions, Inc.——EnviroTechnologies International, Inc——Anthera Pharmaceuticals, Inc.——

Key facts

CEOSteven Basloe

SectorHealthcare

IndustryMedical - Diagnostics & Research

HeadquartersEast Hanover, NJ

ExchangeOTC: PZOO

Employees3

IPO date2012-06-27

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.